News
RELENZA (Zanamivir) 5mg/blister oral inhalation ... of a patient with influenza who received Relenza (zanamivir) inhalation powder which was solubilized and administered by mechanical ventilation.
Learn everything you need to know about Zanamivir-pronunciation ... for the spread of the virus from an infected cell. Adult: Inhalation- Influenza A and B- 10 mg twice daily for 5 days, to ...
RESEARCH TRIANGLE PARK, N.C., Dec. 19 /PRNewswire/ -- GlaxoSmithKline (GSK) is prepared to respond to public health needs for RELENZA(R) (zanamivir) Inhalation Powder this flu season following a ...
oral oseltamivir 75 mg twice daily plus zanamivir 10 mg by inhalation twice daily 2) oral oseltamivir 75 mg twice daily plus inhaled placebo or 3) zanamivir 10 mg by inhalation twice daily plus ...
PHILADELPHIA, Sept. 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today the launch of the RELENZA(R) (zanamivir) Inhalation Powder Pandemic ...
Glaxo Wellcome Inc. is writing to inform you of important revisions to the safety labeling for Relenza (zanamivir for inhalation), which is approved for the treatment of uncomplicated acute ...
February 29, 2008 — Many patients receiving treatment for asthma and chronic obstructive pulmonary disease (COPD) are swallowing capsules of inhalation powder rather than placing them in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results